Načítá se...
Ultrastructure in Transthyretin Amyloidosis: From Pathophysiology to Therapeutic Insights
Transthyretin (TTR) amyloidosis is caused by systemic deposition of wild-type or variant amyloidogenic TTR (ATTRwt and ATTRv, respectively). ATTRwt amyloidosis has traditionally been termed senile systemic amyloidosis, while ATTRv amyloidosis has been called familial amyloid polyneuropathy. Although...
Uloženo v:
| Vydáno v: | Biomedicines |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
MDPI
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6466231/ https://ncbi.nlm.nih.gov/pubmed/30764529 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biomedicines7010011 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|